| Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 … P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ... The Lancet 393 (10167), 143-155, 2019 | 420 | 2019 |
| A meta‐analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale GM Clifford, D Georges, MS Shiels, EA Engels, A Albuquerque, ... International journal of cancer 148 (1), 38-47, 2021 | 327 | 2021 |
| Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study A de Pokomandy, D Rouleau, G Ghattas, S Vézina, P Coté, J Macleod, ... The Journal of infectious diseases 199 (7), 965-973, 2009 | 254 | 2009 |
| Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation C Laprise, A de Pokomandy, JG Baril, S Dufresne, H Trottier Clinical infectious diseases 57 (10), 1489-1496, 2013 | 209 | 2013 |
| HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV A de Pokomandy, D Rouleau, G Ghattas, H Trottier, S Vézina, P Coté, ... Clinical infectious diseases 52 (9), 1174-1181, 2011 | 201 | 2011 |
| Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated … C Orrell, DP Hagins, E Belonosova, N Porteiro, S Walmsley, V Falcó, ... The Lancet HIV 4 (12), e536-e546, 2017 | 141 | 2017 |
| Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infection MA Jenabian, M El-Far, K Vyboh, I Kema, CT Costiniuk, R Thomas, ... The Journal of infectious diseases 212 (3), 355-366, 2015 | 135 | 2015 |
| HIV-related stigma, racial discrimination, and gender discrimination: Pathways to physical and mental health-related quality of life among a national cohort of women living … CH Logie, Y Wang, A Lacombe-Duncan, AC Wagner, A Kaida, T Conway, ... Preventive medicine 107, 36-44, 2018 | 133 | 2018 |
| Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative … F Wei, MM Gaisa, G D'Souza, N Xia, AR Giuliano, SE Hawes, L Gao, ... The Lancet HIV 8 (9), e531-e543, 2021 | 117 | 2021 |
| Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis C Lin, J Slama, P Gonzalez, MT Goodman, N Xia, AR Kreimer, T Wu, ... The Lancet Infectious Diseases 19 (8), 880-891, 2019 | 109 | 2019 |
| Women‐specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDS AJ Carter, S Bourgeois, N O'Brien, K Abelsohn, W Tharao, S Greene, ... African Journal of Reproduction and Gynaecological Endoscopy 16 (1), 2013 | 104 | 2013 |
| Cohort profile: the Canadian HIV women’s sexual and reproductive health cohort study (CHIWOS) M Loutfy, A de Pokomandy, VL Kennedy, A Carter, N O’Brien, ... PloS one 12 (9), e0184708, 2017 | 87 | 2017 |
| Envisioning women-centered HIV care: perspectives from women living with HIV in Canada N O'Brien, S Greene, A Carter, J Lewis, V Nicholson, G Kwaramba, ... Women's Health Issues 27 (6), 721-730, 2017 | 86 | 2017 |
| Hiring, training, and supporting Peer Research Associates: Operationalizing community-based research principles within epidemiological studies by, with, and for women living … A Kaida, A Carter, V Nicholson, J Lemay, N O’Brien, S Greene, W Tharao, ... Harm Reduction Journal 16, 1-13, 2019 | 84 | 2019 |
| Early initiation rather than prolonged duration of antiretroviral therapy in HIV infection contributes to the normalization of CD8 T-cell counts W Cao, V Mehraj, B Trottier, JG Baril, R Leblanc, B Lebouche, J Cox, ... Clinical Infectious Diseases 62 (2), 250-257, 2016 | 84 | 2016 |
| Pathways from HIV-related stigma to antiretroviral therapy measures in the HIV care cascade for women living with HIV in Canada CH Logie, A Lacombe-Duncan, Y Wang, A Kaida, T Conway, K Webster, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 77 (2), 144-153, 2018 | 83 | 2018 |
| Breaking the glass ceiling: increasing the meaningful involvement of women living with HIV/AIDS (MIWA) in the design and delivery of HIV/AIDS services A Carter, S Greene, V Nicholson, N O’Brien, M Sanchez, ... Health care for women international 36 (8), 936-964, 2015 | 70 | 2015 |
| Establishing the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS): operationalizing community-based research in a large national quantitative study M Loutfy, S Greene, VL Kennedy, J Lewis, J Thomas-Pavanel, T Conway, ... BMC medical research methodology 16, 1-9, 2016 | 67 | 2016 |
| Sexual inactivity and sexual satisfaction among women living with HIV in Canada in the context of growing social, legal and public health surveillance A Kaida, A Carter, A de Pokomandy, S Patterson, K Proulx‐Boucher, ... Journal of the International AIDS Society 18, 20284, 2015 | 67 | 2015 |
| Attrition across the HIV cascade of care among a diverse cohort of women living with HIV in Canada G Kerkerian, M Kestler, A Carter, L Wang, N Kronfli, P Sereda, E Roth, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 79 (2), 226-236, 2018 | 65 | 2018 |
